The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Interferon after surgery for women with advanced (Stage II‐IV) epithelial ovarian cancer
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2013
|
DOI | 10.1002/14651858.cd009620.pub2 |
Pubmed ID | |
Authors |
Aramide O Lawal, Alfred Musekiwa, Liesl Grobler |
Abstract |
Epithelial ovarian cancer (EOC) is a life-threatening disease. Most often women become symptomatic only in the advanced stages of the disease, increasing the difficulty of treatment. Whilst the disease responds well to surgery and chemotherapy, the relapse rate is high. New treatments to prevent disease recurrence or progression, prolong survival, and increase the quality of life are needed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 165 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 23 | 14% |
Student > Bachelor | 18 | 11% |
Researcher | 15 | 9% |
Student > Ph. D. Student | 14 | 8% |
Student > Postgraduate | 11 | 7% |
Other | 23 | 14% |
Unknown | 63 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 65 | 39% |
Nursing and Health Professions | 15 | 9% |
Psychology | 5 | 3% |
Agricultural and Biological Sciences | 4 | 2% |
Social Sciences | 4 | 2% |
Other | 12 | 7% |
Unknown | 62 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2013.
All research outputs
#20,723,696
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,914
of 11,842 outputs
Outputs of similar age
#160,211
of 210,295 outputs
Outputs of similar age from Cochrane database of systematic reviews
#268
of 288 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,295 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 288 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.